Gina Consylman

Insider Reports History

Entity
Individual
Location
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gina Consylman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
bluebird bio, Inc. Chief Financial Officer Common Stock 125K $179K $1.43 Feb 1, 2022 Direct
bluebird bio, Inc. Chief Financial Officer Stock Option (right to buy) 50K Feb 1, 2022 Direct
Verastem, Inc. Director Stock Option (right to buy) 25K Jun 28, 2021 Direct
ASSEMBLY BIOSCIENCES, INC. Director Stock Option (right to buy) 2.75K May 29, 2024 Direct

Insider Reports Filed by Gina Consylman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ASMB ASSEMBLY BIOSCIENCES, INC. May 29, 2024 1 $0 4 May 30, 2024 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 25, 2023 1 $0 4 May 30, 2023 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 25, 2022 1 $0 4 May 27, 2022 Director
BLUE bluebird bio, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 Chief Financial Officer
BLUE bluebird bio, Inc. Nov 11, 2021 2 $0 4 Nov 16, 2021 Chief Financial Officer
BLUE bluebird bio, Inc. Nov 4, 2021 0 $0 3 Nov 8, 2021 Chief Financial Officer
VSTM Verastem, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 20, 2021 1 $0 4 May 24, 2021 Director